Allergan plc - Strategy, SWOT and Corporate Finance Report
Summary
Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Allergan plc (Allergan or 'the company') is a pharmaceutical company that develops, manufactures and markets branded pharmaceutical products, biologic, device, surgical and regenerative medicine products. The company offers products in various therapeutic areas, including central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Allergan sells its brand and aesthetic products to drug wholesalers, retailers and distributors, including national retail drug and food store chains, hospitals, clinics, mail order retailers, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has business presence in the US, Europe, Asia and other regions of the world. The company is headquartered in Dublin, Ireland.
Scope
Reasons to Buy
Summary
Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Allergan plc (Allergan or 'the company') is a pharmaceutical company that develops, manufactures and markets branded pharmaceutical products, biologic, device, surgical and regenerative medicine products. The company offers products in various therapeutic areas, including central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Allergan sells its brand and aesthetic products to drug wholesalers, retailers and distributors, including national retail drug and food store chains, hospitals, clinics, mail order retailers, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has business presence in the US, Europe, Asia and other regions of the world. The company is headquartered in Dublin, Ireland.
Scope
- Detailed information on Allergan plc required for business and competitor intelligence needs.
- A study of the major internal and external factors affecting Allergan plc in the form of a SWOT analysis.
- An in-depth view of the business model of Allergan plc including a breakdown and examination of key business segments.
- Intelligence on Allergan plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
- News about Allergan plc, such as business expansion, restructuring, and contract wins.
- Large number of easy-to-grasp charts and graphs that present important data and key trends.
Reasons to Buy
- Gain an understanding of Allergan plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Allergan plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Allergan plc's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Allergan plc: Company Overview
- Allergan plc: Overview and Key Facts
- Allergan plc: Overview
- Allergan plc: Key Facts
- Allergan plc: Key Employees
- Allergan plc: Key Employee Biographies
- Allergan plc: Major Products and Services
- Allergan plc: Company History
- Allergan plc: Management Statement
- Allergan plc: Locations and Subsidiaries
- Allergan plc: Key Competitors
- Allergan plc: Company Analysis
- Allergan plc: Business Description
- Allergan plc: SWOT Analysis
- Allergan plc: SWOT Overview
- Allergan plc: Strengths
- Allergan plc: Weaknesses
- Allergan plc: Opportunities
- Allergan plc: Threats
- Allergan plc: Corporate Financial Deals Activity
- Allergan plc: Financial Deals Overview
- Allergan plc: Targets and Partners
- Allergan plc: Top Deals 2016-2020YTD*
- Allergan plc: Advisors
- Allergan plc: Top Legal Advisors
- Allergan plc: Top Financial Advisors
- Allergan plc: Mergers and Acquisitions
- Allergan plc: Capital Raising
- Allergan plc: Partnership
- Allergan plc: Divestments
- Allergan plc: Private Equity and Ownership
- Allergan plc: Recent Developments
- Allergan plc: News and Events Summary
- Allergan plc: Corporate Social Responsibility
- Allergan plc: Financial Deals
- Allergan plc: Financial Performance
- Allergan plc: Market Developments
- Allergan plc: Red Flags/DistressSignals
- Allergan plc: Regulatory and Legal Events
- Allergan plc: Research & Development
- Appendix
- Contact Us
- Methodology
- About the Author
List of Tables
Table 1: Allergan plc: Key Facts
Table 2: Allergan plc: Key Employees
Table 3: Allergan plc: Company History
Table 4: Allergan plc: Locations and Subsidiaries
Table 5: Allergan plc: Key Competitors
Table 6: Allergan plc: Deal Activity by Deal Type-Volume (TTM*)
Table 7: Allergan plc: Deal Activity by Deal Type-Volume (2016-YTD*2020)
Table 8: Allergan plc: M&A Average Deal Size-Value (US$m)
Table 9: Allergan plc: Targets and Partners
Table 10: Allergan plc: Top Deals 2016-2020YTD*
Table 11: Allergan plc: Legal Advisor Ranking by Value (US$m)
Table 12: Allergan plc: Financial Advisor Ranking by Value (US$m)
Table 13: Allergan plc: M&A Volume and Value Trend (2016-YTD*2020)
Table 14: Allergan plc: M&A Activity by Geography (2016-YTD*2020)
Table 15: Allergan plc: Capital Raising Volume and Value Trend (2016-YTD*2020)
Table 16: Allergan plc: Capital Raising by Deal Type (2016-YTD*2020)
Table 17: Allergan plc: Partnership Volume and Value Trend (2016-YTD*2020)
Table 18: Allergan plc: Partnership Trend by Deal Type (2016-YTD*2020)
Table 19: Allergan plc: Divestments Volume and Value Trend (2016-YTD*2020)
Table 20: Allergan plc: Divestments by Geography (2016-YTD*2020)
Table 21: Allergan plc: Private Equity and Ownership Volume and Value Trend (2016-YTD*2020)
Table 22: Allergan plc: Private Equity and Ownership Volume by Deal Type (2016-YTD*2020)
Table 23: Allergan plc: News and Events Summary
Table 24: Allergan plc: Corporate Social Responsibility
Table 25: Allergan plc: Financial Deals
Table 26: Allergan plc: Financial Performance
Table 27: Allergan plc: Market Developments
Table 28: Allergan plc: Red Flags/DistressSignals
Table 29: Allergan plc: Regulatory and Legal Events
Table 30: Allergan plc: Research & Development
List of Figures
Figure 1: Allergan plc: Deal Activity by Deal Type-Volume (TTM*)
Figure 2: Allergan plc: Deal Activity by Deal Type-Volume (2016-YTD*2020)
Figure 3: Allergan plc: M&A Average Deal Size-Value (US$m)
Figure 4: Allergan plc: M&A Volume and Value Trend (2016-YTD*2020)
Figure 5: Allergan plc: M&A Activity by Geography (2016-YTD*2020)
Figure 6: Allergan plc: Capital Raising Volume and Value Trend (2016-YTD*2020)
Figure 7: Allergan plc: Capital Raising by Deal Type (2016-YTD*2020)
Figure 8: Allergan plc: Partnership Volume and Value Trend (2016-YTD*2020)
Figure 9: Allergan plc: Partnership Trend by Deal Type (2016-YTD*2020)
Figure 10: Allergan plc: Divestments Volume and Value Trend (2016-YTD*2020)
Figure 11: Allergan plc: Divestments by Geography (2016-YTD*2020)
Figure 12: Allergan plc: Private Equity and Ownership Volume and Value Trend (2016-YTD*2020)
Figure 13: Allergan plc: Private Equity and Ownership Volume by Deal Type (2016-YTD*2020)
